Gene and cell therapy is booming worldwide, fueled by major innovations in life science and medicine and funding from global capital markets. To advance this crucial field, GenScript convenes top scientists and industry leaders from around the world, concurrent with the annual JP Morgan Healthcare Conference. The upcoming GenScript Biotech Global Forum 2024 will take place at the Grand Hyatt in San Francisco on Wednesday, January 10, 2024.
Under the theme Innovations and breakthroughs shaping tomorrow's cell and gene therapies, GenScript is inviting gene and cell therapy thought leaders from the research, industry, and capital communities as well as representatives from regulatory bodies to focus on recent developments in research, technological breakthroughs, commercialization challenges, and regulatory trends. We are looking forward to hosting thought leaders from around the world, united in the pursuit of cures to help more patients.
We would like to extend to you a cordial invitation to join your peers at this important event in San Francisco in January 2024.
David Liu, Ph.D.
Professor, Investigator
Broad Institute, Harvard University, and HHMI
Josh Resnick, MD
Senior Managing Director
RA Capital Management
Yi Shi ,Ph.D.
Founding Managing Partner
Lilly Asia Ventures
Simone Fishburn, Ph.D.
Vice President and Editor in Chief
BioCentury
Adrian Bot, Ph.D.
CSO and EVP R&D
Capstan Therapeutics
Alex Goraltchouk
COO
Remedium Bio
Devyn Smith, Ph.D.
CEO
Arbor Biotech
John Mendlein, Ph.D.
Executive Partner
Flagship Pioneering
345 Stockton St, San Francisco, CA, USA, 94108
+1 415-398-1234
https://www.hyatt.com/en-US/hotel/california/grand-hyatt-san-francisco/sfous